Lantern Pharma Inc. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Lantern Pharma Inc. stock issued during period, value, new issues for the quarter ending 2026-06-30 was $146.00.
- Lantern Pharma Inc. stock issued during period, value, new issues for the quarter ending 2024-09-30 was $11.99K.
- Lantern Pharma Inc. stock issued during period, value, new issues for the quarter ending 2024-03-31 was $54.72K.
- Lantern Pharma Inc. stock issued during period, value, new issues for the quarter ending 2021-03-31 was $64.17M, a 123297.80% increase year-over-year.
- Lantern Pharma Inc. stock issued during period, value, new issues for fiscal 2024 was $66.71K.
- Lantern Pharma Inc. stock issued during period, value, new issues for fiscal 2022 was $299.79K, a 99.53% decline from fiscal 2021.
- Lantern Pharma Inc. stock issued during period, value, new issues for fiscal 2021 was $64.17M, a 173.99% increase from fiscal 2020.
- Lantern Pharma Inc. stock issued during period, value, new issues for fiscal 2020 was $23.42M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2026-06-30 | $146.00 10-Q · filed 2026-08-14 | |
| 2024-12-31 | $66.71K 10-K · filed 2026-03-30 | |
| 2024-09-30 | $11.99K 10-Q · filed 2025-11-12 | |
| 2024-03-31 | $54.72K 10-Q · filed 2025-11-12 | |
| 2022-12-31 | $299.79K 10-K · filed 2024-03-18 | |
| 2021-12-31 | $64.17M 10-K · filed 2023-03-20 | |
| 2021-03-31 | $64.17M 10-Q · filed 2022-11-07 | |
| 2020-12-31 | $23.42M 10-K · filed 2022-03-10 | |
| 2020-03-31 | $52.00K 10-Q · filed 2021-11-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |